scholarly journals Non-antibacterial methods for the prevention and treatment of recurrent lower urinary tract infections

2021 ◽  
Vol 9 (3) ◽  
pp. 92-106
Author(s):  
N. D. Kubin ◽  
O. V. Volkova ◽  
D. D. Shkarupa

Urinary tract infections are widespread throughout the world and occupy one of the leading places among infectious diseases. Antibacterial methods are the basis of modern treatment standards. At the same time, a widespread increase in antibiotic resistance of the main uropathogens is currently observed. In clinical practice, recurrent lower urinary tract infections are increasingly common. Following this, the main task of the doctor is to maximize the recurrence-free interval. Given the obvious negative collateral effect of long-term antibiotic prophylaxis, specialists are increasingly turning to alternative methods. Non-antibacterial preventive measures are aimed at key links in the pathogenesis of the disease, such as counteracting the penetration and adhesion of uropathogens, as well as stimulating the immune system of the macroorganism. The available physicians' toolkit includes pharmacological agents (d-mannose, methenamine hippurate, estrogens, non-steroidal anti-inflammatory drugs, probiotics, intravesical glycosaminoglycans, immunostimulants and vaccines), natural uroantiseptics (medicinal herbs and cranberry products), as well as behavioural therapy. The main advantages of non-antibacterial methods for the treatment and prevention of lower urinary tract infections are environmental friendliness. It is associated with the absence of a negative effect on the commensal flora, as well as a reduction in the risk of developing antibiotic resistance. The current guidelines provide very limited information on the application of this approach to treatment. Published studies indicate the high potential of non-antibacterial methods, some of which are comparable in effectiveness to standard therapy. However, the quality of studies and the lack of drug use standards do not allow including this approach in the existing guidelines. The need for new, high-quality clinical trials is evident.

F1000Research ◽  
2018 ◽  
Vol 7 ◽  
pp. 1964 ◽  
Author(s):  
Seung-Ju Lee

Urinary tract infections (UTIs) are among the most common bacterial infections. Traditionally, all symptomatic UTIs are tested and treated. The use of antibiotics has resulted in an antibiotic resistance crisis, and we have limited options for managing UTIs. Currently, we live in the era of antimicrobial resistance and may live in other eras like the era of the microbiome. New insights might provide an opportunity to prevent the overuse and misuse of antibiotics and could enable the development of innovate managing strategies.


2020 ◽  
Vol 35 (2) ◽  
Author(s):  
Daniele Paris ◽  
Mariasofia Caltagirone ◽  
Patrizia Minzulli ◽  
Antonia Valzano ◽  
Fulvio Enrico Ottorino Ferrara ◽  
...  

Urinary tract infections (UTIs) are among the most common bacterial infectious diseases occurring in the community and healthcare setting. Most community-acquired urinary tract infections are usually treated empirically. The knowledge of antibiotic resistance patterns of the microorganisms causing UTI is essential for defining the empirical treatment. The aim of the present study is to investigate the prevalence and the resistance patterns of bacterial species isolated from lower urinary tract infections, in a large population of Milan area. A retrospective analysis of the isolates obtained from urine samples received at the microbiology laboratory of Centro Diagnostico Italiano of Milan was performed from January 2019 to December 2019. Urine samples were plated on differential medium by automated inoculation system. Identification and antibiotic susceptibility testing were performed using the Phoenix 100™ system. All results were interpreted according to the European Committee on Antimicrobial Susceptibility Testing breakpoints. During a 12-month period a total of the 51,980 urine samples have been processed and 21,4% (11.148) were found to be positive (bacterial count ≥105CFU/mL). Overall Escherichia coli was the most common Gram-negative bacteria of all isolates (72%), followed by Klebsiella pneumoniae (10.8%) and Proteus mirabilis (3.3%). Susceptibility of E. coli to oral antimicrobial agents was demonstrated to be as follows: fosfomycin (97%), trimethoprim/sulfamethoxazole (76%), ciprofloxacin (89%), ampicillin (51%) and amoxicillin/clavulanate (77%). The present study point-out the common antibiotic resistance trend of uropathogens in this area. Our results will help in the formulation of antibiotic policy and determination of empirical treatment of urinary tract infection.


1983 ◽  
Vol 103 (2) ◽  
pp. 316-319 ◽  
Author(s):  
Linda Wallen ◽  
W. Patrick Zeller ◽  
Mary Goessler ◽  
Edward Connor ◽  
Ram Yogev

2017 ◽  
Vol 07 (05) ◽  
pp. 532-544
Author(s):  
Ayman Shehata Dawood ◽  
Abdelghaffar Said Dawood ◽  
Salah Abdelmonsef Nagla ◽  
Mohamed Abdelatti El-Bakary

2012 ◽  
Vol 119 ◽  
pp. S727-S727
Author(s):  
J. Renard ◽  
M.T. Da Quinta e Costa de Mascarenhas Sa ◽  
G.J. Wirth ◽  
M. Zahran ◽  
E. Quimper ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document